NCT02435537View on ClinicalTrials.gov

Combined Intrathecal Morphine and Dexmedetomidine Analgesia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Postoperative Pain
Interventions
DRUG

Dexmedetomidine (Precedex)

intrathecal administration

DRUG

Bupivacaine

intrathecal 10 mg bupivacaine

DRUG

Morphine

intrathecal 0.5mg morphine

All Listed Sponsors
lead

Assiut University

OTHER

NCT02435537 - Combined Intrathecal Morphine and Dexmedetomidine Analgesia | Biotech Hunter | Biotech Hunter